DYNAMIC OF LEFT VENTRICULAR VOLUME AFTER ACUTE MYOCARDIAL INFARCTION UNDER THERAPY WITH ACE INHIBITORS

I. Ivanov ,
I. Ivanov

Institute of cardiovascular disease , Sremska Kamenica , Serbia

J. Dejanović ,
J. Dejanović

Institute of cardiovascular disease , Sremska Kamenica , Serbia

I. Čurić ,
I. Čurić

Institute of cardiovascular disease , Sremska Kamenica , Serbia

J. Čikoš ,
J. Čikoš

Institute of cardiovascular disease , Sremska Kamenica , Serbia

M. Vindiš-Ješić ,
M. Vindiš-Ješić

Institute of cardiovascular disease , Sremska Kamenica , Serbia

D. Živkov-Šaponja ,
D. Živkov-Šaponja

Institute of cardiovascular disease , Sremska Kamenica , Serbia

D. Hostić ,
D. Hostić

Institute of cardiovascular disease , Sremska Kamenica , Serbia

M. Mišolić
M. Mišolić

Institute of cardiovascular disease , Sremska Kamenica , Serbia

Published: 01.01.2005.

Volume 33, Issue 1 (2005)

pp. 39-42;

https://doi.org/10.70949/pramed200501110I

Abstract

Change in left ventricular volumes, particularly end-systolic volume index is a major representative of left ventri cular dilatation, and is a predictor of mortality after acute myocardial infarction of anterior localization. Several large-scale trials have demonstrated beneficial effectiveness of ACE inhibitors on the process of left ventricular remodeling after myo cardial infarction, not only in patients with compromised systolic function. Aim of the study was to evaluate the influence of therapy for ACE inhibitors in the early faze of anterior myocardial infarction, trough dynamics of left ventricular volume in dexes. During six months 30 patients were evaluated with echocardiography in admission, before leaving the hospital, after
three and six months after myocardial infarction. In evaluated group there was increased end-diastolic and end-systolic vo lume index, but without statistically significant value. There were no new cardiac decompensations. We concluded that ACE inhibitors given in the early stage of acute myocardial infarction anterior localization have beneficial effect on the process of left ventricular remodeling and that is recommended to bee given to this patients, after excluded contraindications

Keywords

References

1.
Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. New England Journal of Medicine. 319(13):806–11.
2.
Group CCSC. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1. Lancet. 345(8967):686–7.
3.
Group ISIS 4 C. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet. 345(8958):669–85.
4.
Ambrosioni E, Borghi C, Magnani B. for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators. Lancet. 343(8911):1115–22.
5.
Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Circulation. 59(3):421–30.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by